Senseonics Holdings, Inc. (SENS)
USD 0.61
(3.08%)
USD 0.61
(3.08%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 41.19 Million USD | -30.26% |
| 2022 | 59.07 Million USD | -2.16% |
| 2021 | 60.37 Million USD | 2.86% |
| 2020 | 58.69 Million USD | 298.18% |
| 2019 | 14.74 Million USD | -64.02% |
| 2018 | 40.97 Million USD | 182.89% |
| 2017 | 14.48 Million USD | -5.03% |
| 2016 | 15.25 Million USD | 103.36% |
| 2015 | 7.49 Million USD | -23.6% |
| 2014 | 9.81 Million USD | 0.0% |
| 2013 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q1 | 46.79 Million USD | 2.81% |
| 2023 Q4 | 34.2 Million USD | 0.7% |
| 2023 Q3 | 33.96 Million USD | -17.55% |
| 2023 FY | 41.19 Million USD | -30.26% |
| 2023 Q2 | 41.19 Million USD | -11.97% |
| 2022 Q1 | 56.29 Million USD | 4.82% |
| 2022 Q2 | 56.38 Million USD | 0.16% |
| 2022 Q3 | 40.05 Million USD | -28.96% |
| 2022 Q4 | 45.51 Million USD | 13.63% |
| 2022 FY | 59.07 Million USD | -2.16% |
| 2021 Q3 | 48.37 Million USD | -19.88% |
| 2021 FY | 60.37 Million USD | 2.86% |
| 2021 Q1 | 57.97 Million USD | 4.07% |
| 2021 Q2 | 60.37 Million USD | 4.14% |
| 2021 Q4 | 53.7 Million USD | 11.02% |
| 2020 Q1 | 61.34 Million USD | -2.77% |
| 2020 Q3 | 54.21 Million USD | -7.64% |
| 2020 Q4 | 55.71 Million USD | 2.76% |
| 2020 FY | 58.69 Million USD | 298.18% |
| 2020 Q2 | 58.69 Million USD | -4.31% |
| 2019 Q3 | 66.36 Million USD | 350.2% |
| 2019 Q2 | 14.74 Million USD | -84.11% |
| 2019 Q1 | 92.75 Million USD | 134.88% |
| 2019 Q4 | 63.08 Million USD | -4.95% |
| 2019 FY | 14.74 Million USD | -64.02% |
| 2018 Q2 | 40.97 Million USD | -3.74% |
| 2018 Q4 | 39.48 Million USD | -3.89% |
| 2018 Q3 | 41.08 Million USD | 0.28% |
| 2018 FY | 40.97 Million USD | 182.89% |
| 2018 Q1 | 42.56 Million USD | -3.62% |
| 2017 Q1 | 16.86 Million USD | -12.39% |
| 2017 FY | 14.48 Million USD | -5.03% |
| 2017 Q4 | 44.16 Million USD | -4.22% |
| 2017 Q3 | 46.1 Million USD | 218.35% |
| 2017 Q2 | 14.48 Million USD | -14.13% |
| 2016 Q1 | 13.06 Million USD | -10.6% |
| 2016 FY | 15.25 Million USD | 103.36% |
| 2016 Q4 | 19.25 Million USD | -11.02% |
| 2016 Q3 | 21.63 Million USD | 41.88% |
| 2016 Q2 | 15.25 Million USD | 16.69% |
| 2015 Q1 | 9000.00 USD | 0.0% |
| 2015 Q4 | 14.61 Million USD | 86.11% |
| 2015 Q3 | 7.85 Million USD | 5.72% |
| 2015 Q2 | 7.43 Million USD | 82455.56% |
| 2015 FY | 7.49 Million USD | -23.6% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q3 | - USD | -100.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 FY | 9.81 Million USD | 0.0% |
| 2014 Q2 | 9.81 Million USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Perspective Therapeutics, Inc. | - USD | -Infinity% |
| Electromed, Inc. | - USD | -Infinity% |
| Catheter Precision, Inc. | 97 Thousand USD | -42369.072% |
| Xtant Medical Holdings, Inc. | 17.16 Million USD | -139.966% |